EagleCountryOnline.com

Health News

Ebola Outbreaks In Nigeria, Senegal Contained

Posted On October 01, 2014

(Undated) -- The fight to contain Ebola is making big gains in Africa. American and international health officials say outbreaks in Nigeria and Senegal have been contained. It's a welcome development as fears grow that the deadly virus could spread out of control across the continent. The virus is continuing to spread in the hardest-hit…

Hops Compound Found To Boost Brains

Posted On October 01, 2014

(Undated) -- Researchers say a compound found in a basic ingredient of beer can be good for the brain. An Oregon State University study shows a flavonoid found in hops could slow down memory degradation in humans and animals. The study suggests the compound could be used to treat cognitive problems, but it won't be…

Dallas Ebola EMS Crew, Ambulance In Isolation

Posted On October 01, 2014

(Dallas, TX) -- The ambulance and the emergency crew that transported an Ebola patient in Dallas, are now in isolation. Norman Seals with Dallas Fire and Rescue says the EMS crew will be quarantined for several days.   Mayor Mike Rawlings says both emergency medical services crew members have been quarantined while doctors determine whether…

Primary Care Trying To Make A Comeback

Posted On October 01, 2014

(Undated) -- A new study shows that 50-million Americans are not accessing primary care causing more visits to the emergency room. Researchers from the UnitedHealth Center for reform and modernization have found that an estimated 70-percent of ER visits are for non-emergency related cases that would be better handled in a primary care setting. The…

Johnson & Johnson Buying Private Drug Maker

Posted On October 01, 2014

(Undated) -- Johnson & Johnson is buying up private drug developer Alios BioPharma for just under two-billion dollars. Johnson has recently focused efforts on developing treatments for infectious diseases. Alios is developing an experimental drug to treat infants with a serious respiratory virus, which would complement Johnson's portfolio.